Kevin E. Noonan

Kevin E. Noonan, PhD, is a partner at McDonnell Boehnen Hulbert & Berghoff LLP.

Articles by Kevin E. Noonan

November 6th 2020

Opposition to IP protection for COVID-19 vaccines, therapies, tests and other technologies may only prevent eradication and treatment of the disease.

March 1st 2017

A controversial naming convention attempts to explain important distinctions between biologic drugs and their biosimilar counterparts.